Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2025-12-24 @ 6:31 PM
NCT ID:
NCT00449657
Eligibility Criteria:
Inclusion Criteria:
1. Patients must have: IIIA or IIIB non-small cell lung cancer by radiographic or surgical staging, excluding: superior sulcus tumors, tumors with associated atelectasis or obstructive pneumonitis of the entire lung, and tumors with a malignant pleural effusion.
2. Patients will be included in the study based on the following criteria:
* Patients must be older than 18 years old.
* Patients must have a Zubrod performance status of 0 to 2
* Patients with adequate bone marrow function
* Patients with adequate renal function
* Patients with adequate hepatic function
* Patients of childbearing potential must have a negative serum pregnancy test and use an effective form of contraception.
* Patients who are suitable for treatment with radical intent using concurrent chemotherapy and radiation.
* Patients who have signed an approved informed consent and authorization permitting release of personal health information.
Exclusion Criteria:
1. Disease-Specific Exclusions
* Superior sulcus tumors
* Atelectasis or obstructive pneumonitis of the entire lung
* Malignant pleural effusion
2. General Medical Exclusions
* Surgical candidates
* Patients who are pregnant at the time of diagnosis
* Serious concomitant systemic disorders incompatible with the study
* Inability to comply with study and/or follow-up procedures
* Life expectancy of less than 12 weeks
* Current, recent (within 4 weeks of the first infusion of this study), or planned participation in an experimental drug study
* Patients with septicemia or severe infection.
* Patients who have circumstances that will not permit completion of this study or the required follow-up
* Patients with any contraindication to gemcitabine, carboplatin, or paclitaxel
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00449657
Study Brief:
Protocol Section:
NCT00449657